Neoadjuvant Trastuzumab Plus Chemo in Primary Breast CancerNeoadjuvant Trastuzumab Plus Chemo in Primary Breast Cancer

Does the pathological complete response rate to trastuzumab in HER2-positive breast cancer depend on the level of HER2 mRNA expression? Breast Cancer Research
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news